Global Studies Asset Manager (GSAM) at Roche/Genentech is responsible for the consistent and efficient execution of global operations related to studies within a Disease Area (DA) or Therapeutic Area (TA). The role involves working closely with internal teams, partner operations, cross-functional experts, and vendor partners to ensure smooth operational delivery. The ASM is a vital member of the Extended Study Management Team (SMT) and provides operational expertise to ensure consistency and efficiency across assigned studies.
Roche, with its Pharma Product Development Global Clinical Operations (PDG), is committed to transforming drug development to deliver transformative medicines by 2029 addressing diseases with the highest societal burden. PD's mission is to improve patients' lives globally through unique medicines in areas like Oncology, Hematology, Neurology, Immunology, and more.
The GASM coordinates and delivers study management aspects within an asset’s portfolio following IHC-GCP and Roche processes to ensure clinical studies progress as planned, develop essential study documents, contribute to study recruitment, drive innovation in clinical operations, oversee key performance indicators, maintain inspection readiness, select 3rd party vendors, and more.